180 Life Sciences Corp.

NASDAQ: ATNF · Real-Time Price · USD
7.09
-0.52 (-6.83%)
At close: Aug 15, 2025, 3:59 PM
7.20
1.55%
After-hours: Aug 15, 2025, 07:58 PM EDT

180 Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
2.22M 3.72M 4.59M 194.92K 1.15M 675.98K 1.98M 2.66M 2.01M 2.65M 6.97M 3.59M 1.63M 5.67M 8.22M 11.69M 1.84M 6.05M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -15.66M n/a n/a n/a -9.71M n/a n/a n/a
Receivables
10.78K 9.99K 41.19K 44.35K 9.96K 10.22K 279.04K 369.91K 355.16K 770.36K 310.02K 38.31K 83.69K n/a 80.78K n/a n/a 300K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
60.3K n/a n/a n/a n/a n/a 450.08K -239.5K -265.67K n/a 310.95K 2.47M 2.02M n/a 613.77K n/a n/a n/a
Total Current Assets
3.09M 4.03M 5.14M 1.23M 2.35M 1.85M 3.64M 3.37M 2.93M 4.2M 8.93M 6.51M 4.65M 8.96M 11.2M 13.63M 4.05M 8.3M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
7.62M 7.62M 7.62M 9.24M 1.56M 1.59M 1.62M 1.59M 10.73M 10.73M 10.72M 27.82M 48.71M 50.72M 51.51M 51.44M 52.22M 51.81M
Total Long-Term Assets
7.62M 7.62M 7.62M 9.24M 1.56M 1.59M 1.62M 1.59M 10.73M 10.73M 10.72M 27.82M 48.71M 50.72M 51.51M 51.44M 52.22M 51.81M
Total Assets
10.71M 11.65M 12.76M 10.47M 3.91M 3.44M 5.26M 4.96M 13.67M 14.92M 19.65M 34.34M 53.36M 59.68M 62.71M 65.07M 56.27M 60.11M
Account Payables
2.2M 2.12M 1.93M 2.09M 2.92M 1.84M 1.89M 1.71M 836.99K 1.21M 1.8M 1.02M 1.59M 1.04M 586.61K 638.58K 2.53M 3.91M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.98M 2.34M 2.17M 3.63M
Short-Term Debt
1.41M 148.39K 147.89K 473.14K 429K 772.33K 1.03M 332.88K 588.22K 842.2K 1.31M 406.45K 889.32K 1.38M 1.91M 360.53K 1.52M 1.71M
Other Current Liabilities
n/a n/a n/a 3.15M n/a 50.25K 50.06K 55.6K 75.76K 1.33M 200.64K 1.27M 2.74M 11.02M 13.54M 18.99M 41.41M 20.51M
Total Current Liabilities
5.33M 3.94M 3.5M 6.38M 4.02M 4.08M 5.06M 4.81M 4.27M 5.12M 5.66M 4.72M 6.97M 15.08M 19.7M 24.22M 49.8M 33.62M
Long-Term Debt
n/a 3.42K 6.62K 10.57K 13.29K 16.54K 19.94K 22.22K 26.31K 28.73K 31.19K 31.52K 37.34K 43.61K 48.16K 52.1K 70.02K 107.96K
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 31.19B n/a n/a 31.08K n/a n/a n/a n/a
Total Long-Term Liabilities
n/a 3.42K 6.62K 352.25K 313.31K 315.9K 324.59K 300.57K 2.68M 2.66M 2.65M 3.54M 3.6M 3.7M 3.69M 3.7M 3.75M 3.78M
Total Liabilities
5.33M 3.95M 3.51M 6.74M 4.33M 4.4M 5.39M 5.11M 6.95M 7.78M 8.31M 8.26M 10.57M 18.77M 23.39M 27.93M 53.55M 37.4M
Total Debt
1.41M 151.82K 154.5K 483.72K 442.29K 788.88K 1.05M 355.1K 614.53K 870.93K 1.34M 437.97K 926.66K 1.43M 1.96M 412.63K 1.59M 1.81M
Common Stock
604.00 519.00 318.00 103.00 95.00 86.00 54.00 674.00 532.00 375.00 375.00 3.92K 3.41K 3.41K 3.4K 3.4K 3.11K 3.05K
Retained Earnings
-145.62M -143.89M -141.52M -129.24M -128.4M -128.41M -127.34M -126.12M -115.85M -112.17M -107.41M -85.67M -64.18M -67.12M -68.68M -69.72M -88.02M -64.56M
Comprehensive Income
-3.13M -2.98M -2.92M -2.98M -2.92M -2.89M -2.9M -2.85M -2.9M -2.88M -2.89M -3.69M -1.82M 89.36K 817.44K 701.9K 1.23M 826.23K
Shareholders Equity
5.38M 7.71M 9.25M 3.73M -417.99K -954.47K -127.73K -149.33K 6.72M 7.14M 11.34M 26.08M 42.79M 40.9M 39.32M 37.14M 2.72M 22.71M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a